Career history of Nathalie Brun
Former positions of Nathalie Brun
| Companies | Position | Start | End |
|---|---|---|---|
| ELSALYS BIOTECH | Director of Finance/CFO | 2017-06-30 | 2019-08-31 |
Axxès SAS
 Axxès SAS Other TransportationTransportation Axxès SAS provides toll and parking fee collection services. The company is headquartered in Lyon, France. | Chief Administrative Officer | 2005-06-30 | 2007-11-30 |
| Director of Finance/CFO | 2005-06-30 | 2007-11-30 | |
| AKKA TECHNOLOGIES SE | Chief Administrative Officer | 1995-12-31 | 2001-03-31 |
| Director of Finance/CFO | 1995-12-31 | 2001-03-31 |
Training of Nathalie Brun
| EM Lyon Business School | Graduate Degree |
Statistics
International
| France | 4 |
| Belgium | 2 |
Operational
| Director of Finance/CFO | 3 |
| Chief Administrative Officer | 2 |
| Graduate Degree | 1 |
Sectoral
| Commercial Services | 2 |
| Consumer Services | 2 |
| Transportation | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 3 |
|---|---|
AKKA Technologies SE
 AKKA Technologies SE Miscellaneous Commercial ServicesCommercial Services AKKA Technologies SE engages in the provision of engineering consulting and research and development services in the mobility sector. It operates through the following geographical segments: France, Germany, North America, International, Data Respons, and Other. The firm offers software engineering, systems engineering, and mechanical and thermal engineering solutions. The company was founded by Maurice Ricci on April 1, 1984 and is headquartered in Brussels, Belgium. | Commercial Services |
Axxès SAS
Axxès SAS Other TransportationTransportation Axxès SAS provides toll and parking fee collection services. The company is headquartered in Lyon, France. | Transportation |
ElsaLys Biotech SAS
 ElsaLys Biotech SAS Pharmaceuticals: MajorHealth Technology ElsaLys Biotech SAS provides therapeutic monoclonal antibody player services. It involves in cellular events at the core of the pathological process: immune response, angiogenesis, survival, proliferation, adhesion and migration. The company also designs and develops a new generation of antibodies that target tumors and their immune microenvironment. ElsaLys Biotech was founded by Christine Guillen, Thierry Menguy, Vanessa Duong, and Martine Brandt in 2013 and is headquartered in Lyon, France. | Health Technology |
- Stock Market
- Insiders
- Nathalie Brun
- Experience
